Introduction
Nowadays, some conditions have become more prevalent and more dangerous, especially gender-specific ones. The most frequent cause of death for women with diagnoses of cancer is ovarian cancer (Arora et al., 2021). Overall, it ranks as the fifth most common cause of mortality for women (Arora et al., 2021). The small organs in the female reproductive system, called ovaries, are the first location where ovarian cancer develops (Arora et al., 2021). Thus, compared with other types of cancers, ovarian cancer has higher mortality due to its discrete and hidden nature, requiring more tests and prompt treatment.
Dangers of Ovarian Cancer
First, it is noteworthy that ovarian cancer may not exhibit any signs when it first appears. Symptoms of this cancer are typically misdiagnosed as other, more prevalent illnesses (Mayo Clinic, 2023). In general, ovarian cancer symptoms and signs can include bloating or swelling in the abdomen, loss of weight, discomfort in the lower abdomen, back discomfort, and alterations in digestive patterns, such as constipation and an ongoing urge to urinate (Mayo Clinic, 2023). It is crucial to remember that these symptoms are not always indicative of ovarian cancer; several other illnesses can also bring them on. For additional assessment, it is imperative to speak with a healthcare provider if these symptoms worsen or continue.
Second, an extensive physical examination should be performed in clinical settings with a high degree of suspicion. This initially involves a rectovaginal examination of an empty bladder to search for tumors (Arora et al., 2021). A palpable pelvic mass, ascites, or reduced breath sounds because of pleural effusions may be detected in advanced instances (Arora et al., 2021). A diagnostic indication of occult cancer is the Lesar-Trélat sign, defined as a dramatic increase in the detection of seborrheic keratosis (Arora et al., 2021).
Moreover, compared to breast cancer, ovarian cancer is less common, but it is nearly three times more deadly (Momenimovahed et al., 2019). Several factors influence the prognosis for ovarian cancer, including the patient’s response to treatment, the tumor’s aggressiveness, the stage at diagnosis, and the kind of ovarian cancer (Carlton et al., 2019). This type of condition has a high death rate because of the tumor’s hidden and discrete growth, delayed onset of signs, and inadequate screening (Momenimovahed et al., 2019). Consequently, these factors might lead to an advanced-stage diagnosis.
Finally, the appearance of the condition must be discussed. Radiological imaging, such as transvaginal ultrasound (TVUS; extremely sensitive and recommended) and/or abdominal and pelvic ultrasonography, is performed in individuals with a high clinical suspicion (Arora et al., 2021). It provides a reasonable understanding of the ovarian mass’s dimensions, location, and complexity (Arora et al., 2021). Additional imaging, including a pelvic MRI, a chest and abdomen CT scan, or a PET scan, can be performed to determine the extent of the tumor (Arora et al., 2021). Overall, ovarian tumors can show up on imaging as solid masses, cystic formations, or a mix of the two.
Conclusion
In summary, since ovarian cancers are concealed, requiring additional examinations and early care, they are more lethal than cancers of other organs. It is crucial to keep in mind that this condition may not manifest any symptoms initially. In high-concern contexts, such as healthcare facilities, a comprehensive physical examination should be performed. Ovarian malignancies can manifest on imaging as solid masses, cystic masses, or a combination of both.
References
Arora, T., Mullangi, S., & Lekkala, M. R. (2021). Ovarian cancer. National Library of Medicine.
Carlton, R. R., Adler, A. M., & Balac, V. (2019). Principles of radiographic imaging: An art and a science (6th ed.). Cengage Learning.
Mayo Clinic. (2023). Ovarian cancer.
Momenimovahed, Z., Tiznobaik, A., Taheri, S., & Salehiniya, H. (2019). Ovarian cancer in the world: Epidemiology and risk factors. International Journal of Women’s Health, 11, 287–299.